Course Provider
Salt City Psychedelic Therapy and Research (SCPTR) is a Utah-based nonprofit founded by the late Dr. Parth Gandhi to advance psychedelic-assisted therapy through education, research, and advocacy in the Intermountain West. SCPTR organizes the annual Intermountain Psychedelic Symposium and supports practitioners, researchers, and policy reform in the region.
SCPTR looks like a small, regionally rooted psychedelic-therapy educator rather than a large commercial training brand. The strongest public evidence points to an 8-week ketamine-leaning clinician course, with clinical, ethical and research basics and some notable lineage through MAPS and CIIS faculty references. Reputation-wise, it seems to have had a real local footprint in Utah, but the programme is now reported as no longer live, and there is little independently verifiable student-review material beyond a few practitioner mentions.
Best suited to mental health or allied professionals who want an introductory, practice-facing grounding in psychedelic-assisted therapy, especially ketamine and broader psychedelic harm reduction and ethics. It also appears relevant to people seeking regional professional community rather than a standalone formal qualification.
No firm prerequisite list was found on the public sources consulted. The course is described as aimed at aspiring therapists and healers, and secondary references frame it as a professional development programme for clinicians, but explicit licensure or entry conditions were not verifiable.
Blossom’s course listing identifies CE, not CME. I could not verify any formal licensure, board certification, or regulator-approved psychedelics credential from SCPTR itself in the sources found.
Blossom’s course listing gives a cost of 1925 for the programme. The conserved course description says the training included live Zoom sessions, weekly process groups, and optional one-to-one integration sessions; however, an exact inclusion breakdown from SCPTR itself was not verifiable.
Learners appear to walk away with an introductory understanding of psychedelic-assisted therapy, including harm reduction, ethics, research, and modality-specific exposure to MDMA, psilocybin, and ketamine-assisted psychotherapy. The practical outcome seems to be professional readiness and regional network-building rather than a clearly stated formal credential.
Linked Courses
1
Active Listings
0
Primary Formats
Live Classes
Programs linked directly to this provider in the Blossom course dataset.
Reference points selected from shared training modalities, learner audience, level, delivery format, pricing, and location.